These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11728350)

  • 1. Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial.
    Angeja BG; Alexander JH; Chin R; Li X; Barron HV; Armstrong PW; Granger CB; Van de Werf F; Gibson CM
    Am J Cardiol; 2001 Dec; 88(11):1240-5. PubMed ID: 11728350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.
    Van de Werf F; Barron HV; Armstrong PW; Granger CB; Berioli S; Barbash G; Pehrsson K; Verheugt FW; Meyer J; Betriu A; Califf RM; Li X; Fox NL;
    Eur Heart J; 2001 Dec; 22(24):2253-61. PubMed ID: 11728145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
    Cannon CP; Gibson CM; McCabe CH; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Giugliano RP; Frey M; Mueller HS; Steingart RM; Weaver WD; Van de Werf F; Braunwald E
    Circulation; 1998 Dec 22-29; 98(25):2805-14. PubMed ID: 9860780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators.
    Van de Werf F; Cannon CP; Luyten A; Houbracken K; McCabe CH; Berioli S; Bluhmki E; Sarelin H; Wang-Clow F; Fox NL; Braunwald E
    Am Heart J; 1999 May; 137(5):786-91. PubMed ID: 10220625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA).
    Gibson CM; Marble SJ
    Clin Cardiol; 2001 Sep; 24(9):577-84. PubMed ID: 11558838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).
    Curtis JP; Alexander JH; Huang Y; Wallentin L; Verheugt FW; Armstrong PW; Krumholz HM; Van de Werf F; Danays T; Cheeks M; Granger CB;
    Am J Cardiol; 2004 Aug; 94(3):279-83. PubMed ID: 15276088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
    Gabrail N; Sandler E; Charu V; Anas N; Lim E; Blaney M; Ashby M; Gillespie BS; Begelman SM
    J Vasc Interv Radiol; 2010 Dec; 21(12):1852-8. PubMed ID: 21111365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
    Giugliano RP; McCabe CH; Antman EM; Cannon CP; Van de Werf F; Wilcox RG; Braunwald E;
    Am Heart J; 2001 May; 141(5):742-50. PubMed ID: 11320361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
    Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
    Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of a weight-adjusted dose of TNK-tissue plasminogen activator.
    Wang-Clow F; Fox NL; Cannon CP; Gibson CM; Berioli S; Bluhmki E; Danays T; Braunwald E; Van De Werf F; Stump DC
    Am Heart J; 2001 Jan; 141(1):33-40. PubMed ID: 11136484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative fibrinolytic activity of front-loaded alteplase and the single-bolus mutants tenecteplase and lanoteplase during treatment of acute myocardial infarction.
    Al-Shwafi KA; de Meester A; Pirenne B; Col JJ
    Am Heart J; 2003 Feb; 145(2):217-25. PubMed ID: 12595837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
    ; Van De Werf F; Adgey J; Ardissino D; Armstrong PW; Aylward P; Barbash G; Betriu A; Binbrek AS; Califf R; Diaz R; Fanebust R; Fox K; Granger C; Heikkilä J; Husted S; Jansky P; Langer A; Lupi E; Maseri A; Meyer J; Mlczoch J; Mocceti D; Myburgh D; Oto A; Paolasso E; Pehrsson K; Seabra-Gomes R; Soares-Piegas L; Sùgrue D; Tendera M; Topol E; Toutouzas P; Vahanian A; Verheugt F; Wallentin L; White H
    Lancet; 1999 Aug; 354(9180):716-22. PubMed ID: 10475182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy.
    Serebruany VL; Malinin AI; Callahan KP; Binbrek A; Van De Werf F; Alexander JH; Granger CB; Gurbel PA;
    Am Heart J; 2003 Apr; 145(4):636-42. PubMed ID: 12679759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction.
    Armstrong PW; Wagner G; Goodman SG; Van de Werf F; Granger C; Wallentin L; Fu Y;
    Eur Heart J; 2003 Aug; 24(16):1515-22. PubMed ID: 12919776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An angiographic trial to evaluate the efficacy and safety of tenecteplase in Chinese patients with acute myocardial infarction].
    Liang F; Wang LZ; Hu DY; Shi XB; Wei JP; Zhao H; Wang L; Jia SQ; Wang HY; Liu RH; Chen YD; Lu YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):514-7. PubMed ID: 19927632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.
    Armstrong PW; Zheng Y; Westerhout CM; Rosell-Ortiz F; Sinnaeve P; Lambert Y; Lopes RD; Bluhmki E; Danays T; Van de Werf F;
    Am Heart J; 2015 Jun; 169(6):890-898.e1. PubMed ID: 26027628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators.
    Gibson CM; Cannon CP; Murphy SA; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Fox NL; Berioli S; Weaver WD; Van de Werf F; Braunwald E
    Am J Cardiol; 1999 Nov; 84(9):976-80. PubMed ID: 10569649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase for treatment of acute myocardial infarction.
    Turcasso NM; Nappi JM
    Ann Pharmacother; 2001 Oct; 35(10):1233-40. PubMed ID: 11675853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction.
    Sinnaeve P; Alexander J; Belmans A; Bogaerts K; Langer A; Diaz R; Ardissino D; Vahanian A; Pehrsson K; Armstrong P; Van de Werf F;
    Am Heart J; 2003 Jul; 146(1):27-32. PubMed ID: 12851604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.